Key factors in the discovery and development of new antiepileptic drugs

作者: Meir Bialer , H. Steve White

DOI: 10.1038/NRD2997

关键词: Key factorsIntensive care medicinePharmacologyRefractory seizuresEpilepsyEpileptogenesisDiseaseMedicineTolerabilityDrug discoveryGeneral Medicine

摘要: Despite an arsenal of antiepileptic drugs, ∼30% patients with epilepsy are not free from seizures. This article reviews the emerging understanding molecular basis and experimental models disease, how they might be used in design new therapeutics. Since early 1990s, many drugs (AEDs) that offer appreciable advantages terms their favourable pharmacokinetics, improved tolerability lower potential for drug–drug interactions have entered market. However, despite therapeutic old AEDs, approximately 30% still suffer Thus, there remains a substantial need development more efficacious AEDs refractory Here, we briefly review knowledge on pathological it best We also discuss current approach to AED discovery highlight some unique features newer pharmacoresistance epileptogenesis emerged recent years.

参考文章(117)
L. James Willmore, James W. Wheless, Roger A. Brumback, Advanced Therapy in Epilepsy ,(2009)
Y Bersudsky, J Applebaum, Y Gaiduk, L Sharony, A Mishory, A Podberezsky, G Agam, RH Belmaker, Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial Bipolar Disorders. ,vol. 12, pp. 376- 382 ,(2010) , 10.1111/J.1399-5618.2010.00828.X
Nina Isoherranen, H. Steve White, Brian D. Klein, Michael Roeder, José H. Woodhead, Volker Schurig, Boris Yagen, Meir Bialer, Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy. Pharmaceutical Research. ,vol. 20, pp. 1293- 1301 ,(2003) , 10.1023/A:1025069519218
Solomon Moshe, Philip A Schwartzkroin, Asla Pitkanen, Models of Seizures and Epilepsy ,(2005)
Yoshihiko Funae, Yukio Kuroiwa, Takemi Yoshida, Toshinori Yamamoto, Kanae Iwata, Miki Nakajima, Nicotine Metabolism in Liver Microsomes from Rats with Acute Hepatitis or Cirrhosis Drug Metabolism and Disposition. ,vol. 26, pp. 36- 41 ,(1998)
Cyrille Sur, Keith A. Wafford, David S. Reynolds, Karen L. Hadingham, Frances Bromidge, Alison Macaulay, Neil Collinson, Gillian O'Meara, Owain Howell, Richard Newman, Janice Myers, John R. Atack, Gerard R. Dawson, Ruth M. McKernan, Paul J. Whiting, Thomas W. Rosahl, Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice The Journal of Neuroscience. ,vol. 21, pp. 3409- 3418 ,(2001) , 10.1523/JNEUROSCI.21-10-03409.2001
Ilan Winkler, Simcha Blotnik, Jakob Shimshoni, Boris Yagen, Marshall Devor, Meir Bialer, Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain British Journal of Pharmacology. ,vol. 146, pp. 198- 208 ,(2005) , 10.1038/SJ.BJP.0706310
Nanda A. Singh, James F. Otto, E. Jill Dahle, Chris Pappas, Jonathan D. Leslie, Alex Vilaythong, Jeffrey L. Noebels, H. Steve White, Karen S. Wilcox, Mark F. Leppert, Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization The Journal of Physiology. ,vol. 586, pp. 3405- 3423 ,(2008) , 10.1113/JPHYSIOL.2008.154971